{"id":"F2005L00777","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2005)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2005","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":113050,"registerId":"commonwealth-F2005L00777-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2005)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 1 of 2005\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 April 2005.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nDiphtheria Antitoxin\n\nFerrous Sulfate - Dried with Folic Acid\n\nLevamisole Hydrochloride\n\nTetracycline Hydrochloride\n\nDated this twenty second day of March 2005.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":3022},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This declaration exercises the specific power under section 85(2AA) of the National Health Act 1953 to remove specified drugs from PBS coverage. It precisely targets the administrative delisting of four specific medications without expanding beyond the original statutory purpose of managing the pharmaceutical benefits formulary."},"complexity_factors":["No defined terms section","Only four items listed in the Schedule","Single operative clause with no conditions, exceptions, or nested logic","Minimal cross-referencing limited to the enabling provision (s 85(2AA))","No subordinate legislation or delegated powers within the instrument"],"plain_english_summary":"This declaration removes four medicines (diphtheria antitoxin; ferrous sulfate with folic acid; levamisole hydrochloride; tetracycline hydrochloride) from Australia’s Pharmaceutical Benefits Scheme from 1 April 2005, so they are no longer government-subsidised.\n\nAn Assistant Secretary of the Department of Health and Ageing made the decision as delegate of the Health Minister after PBAC advice. Patients will face full commercial prices or need alternative PBS-listed treatments; delisting commonly reflects obsolescence, rare use, or cheaper equivalents."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2005","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2005/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2005/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2005/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2005/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2005/documents"}}